Login with your work email address to view charts. No credit card required.
| Art Unit: | 1678 — Chemistry: molecular biology and microbiology |
|---|---|
| Group: | 1670 — Virology, Viral Immunology, And Viral Pathogens, Neurology, Receptors, Cytokines & Recombinant Hormones and Immunoassays and related devices |
| Classes: |
435 — Chemistry: molecular biology and microbiology 436 — Chemistry: analytical and immunological testing 506 — Combinatorial chemistry technology: method, library, apparatus 250 — Radiant energy 702 — Data processing: measuring, calibrating, or testing 514 — Drug, bio-affecting and body treating compositions 424 — Drug, bio-affecting and body treating compositions |
| Phone: | (571) 272-0820 |
| Email: | gailene.gabel@uspto.gov |
| Location: | VA 22314 |
| Title: | Pat Examnr Biolgy |
| Service: | 28 years |
| Grade: | GS-14 |
| 3-Year Grant rate: | 70% over 304 cases |
|---|---|
| Difficulty: | Harder |
| Difficulty Percentile: | 61st
|
With Examiner Gabel, you have a 70% chance of getting an issued patent by 3 years after the first office action. Examiner Gabel is a harder examiner and in the 61st percentile across all examiners (with 100th percentile most difficult).
Below is the grant rate timeline for Examiner Gabel, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.
Examiner Gabel's grant rate is higher than that of Art Unit 1678 and lower than that of the USPTO.
| Average Office Actions Per Grant | |
|---|---|
| Examiner Gabel | 1.7 |
| Art Unit 1678 | 1.9 |
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.
Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.